Cladribine in combination with mitoxantrone and cyclophosphamide(CMC) in the treatment of heavily pre-treated patients with advanced indolent lymphoid malignancies.
about
Cladribine combined with cyclophosphamide and mitoxantrone is an active salvage therapy in advanced non-Hodgkin's lymphoma.Evolving role of ribonucleoside reductase inhibitors in hematologic malignancies.Current status of older and new purine nucleoside analogues in the treatment of lymphoproliferative diseases.Anthracyclines potentiate activity against murine leukemias L1210 and P388 in vivo and in vitro.Activity of cladribine combined with etoposide in heavily pretreated patients with indolent lymphoid malignancies.
P2860
Cladribine in combination with mitoxantrone and cyclophosphamide(CMC) in the treatment of heavily pre-treated patients with advanced indolent lymphoid malignancies.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Cladribine in combination with mitoxantrone and cyclophosphamide
@nl
Cladribine in combination with ...... ndolent lymphoid malignancies.
@ast
Cladribine in combination with ...... ndolent lymphoid malignancies.
@en
type
label
Cladribine in combination with mitoxantrone and cyclophosphamide
@nl
Cladribine in combination with ...... ndolent lymphoid malignancies.
@ast
Cladribine in combination with ...... ndolent lymphoid malignancies.
@en
prefLabel
Cladribine in combination with mitoxantrone and cyclophosphamide
@nl
Cladribine in combination with ...... ndolent lymphoid malignancies.
@ast
Cladribine in combination with ...... ndolent lymphoid malignancies.
@en
P2093
P2860
P1476
Cladribine in combination with ...... indolent lymphoid malignancies
@en
P2093
E Lech-Marańda
J Z Błoński
M Kasznicki
P2860
P304
P356
10.1034/J.1600-0609.2001.00303.X
P577
2001-03-01T00:00:00Z